Bal Pharma

122.23
+13.89
(12.82%)
Market Cap
194.60 Cr
EPS
4.94
PE Ratio
23.91
Dividend Yield
1.09 %
Industry
Healthcare
52 Week High
157.98
52 Week Low
78.06
PB Ratio
2.52
Debt to Equity
2.03
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,709.35
#1 4,10,130.32
36.01
#1 49,887.20
12.06
#1 9,648
13.77
49.12
5,482.85
1,45,552.44
74.00
8,184.00
0.89
1,600
#1 64.53
40.03
1,415.25
1,14,297.70
24.20
26,520.70
14.17
4,155
47.38
40.43
3,286.50
1,11,230.09
59.07
10,785.70
11.59
1,656
13.54
63.02
2,451.20
1,01,131.25
49.07
10,615.60
19.57
1,942
-16.38
58.29
1,109.95
92,620.37
#1 17.88
28,905.40
12.36
5,578
1.69
35.77
1,971.05
89,986.50
33.34
20,141.50
#1 19.94
1,936
38.82
44.59
866.90
87,230.42
20.00
19,831.50
13.82
3,831
29.92
38.62
1,105.35
64,198.91
19.37
29,559.20
17.55
3,169
-10.04
42.94
29,077.40
61,787.45
47.68
6,097.20
10.80
1,201
16.01
41.67
Growth Rate
Revenue Growth
12.09 %
Net Income Growth
184.62 %
Cash Flow Change
1,581.17 %
ROE
161.56 %
ROCE
27.96 %
EBITDA Margin (Avg.)
17.68 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
51
41
57
48
54
45
66
58
65
52
56
54
58
54
54
49
45
44
35
52
65
63
72
71
68
70
78
70
75
77
83
71
93
82
97
75
74
74
Expenses
47
38
52
43
53
41
62
55
61
47
50
50
53
50
49
48
43
43
33
47
58
57
65
63
61
63
71
65
70
71
74
64
85
74
85
68
66
65
EBITDA
3
3
4
5
1
4
4
3
4
5
5
5
4
5
5
2
2
1
2
5
7
6
7
8
7
7
7
5
6
7
8
7
8
8
12
7
8
8
Operating Profit %
5 %
6 %
6 %
10 %
2 %
6 %
4 %
4 %
5 %
9 %
8 %
7 %
7 %
7 %
11 %
3 %
4 %
2 %
2 %
10 %
11 %
9 %
9 %
11 %
9 %
9 %
5 %
7 %
8 %
8 %
10 %
9 %
8 %
10 %
10 %
9 %
10 %
11 %
Depreciation
4
2
2
2
2
2
1
1
2
2
2
1
1
1
2
1
1
1
4
2
2
2
3
2
2
2
2
2
2
3
2
3
2
3
2
2
3
3
Interest
2
1
1
2
2
2
2
2
2
2
2
3
3
3
4
3
3
3
3
3
3
3
3
3
3
2
3
2
3
3
4
4
4
4
4
4
4
5
Profit Before Tax
0
0
2
2
-2
1
2
0
-1
1
1
1
-0
1
-1
-3
-3
-3
-5
1
2
1
1
3
2
2
2
1
1
1
2
0
2
1
6
1
1
1
Tax
0
0
1
1
1
0
1
1
1
0
1
-1
1
-1
-2
-0
-1
1
-0
0
1
1
-3
1
1
2
0
0
1
1
1
0
1
0
0
0
0
0
Net Profit
0
0
2
1
-3
1
1
-0
-2
1
1
2
-1
2
1
-3
-2
-4
-5
0
1
0
4
2
1
1
2
0
0
1
2
0
1
1
6
0
1
1
EPS in ₹
0.26
0.21
1.52
1.52
-0.24
0.04
0.12
0.43
-1.29
0.24
0.45
1.12
-0.53
1.12
0.77
-1.74
-1.29
-2.52
-3.21
0.30
0.30
0.22
2.52
1.09
0.97
0.32
1.33
0.19
0.08
0.38
1.03
0.06
0.62
0.54
3.73
0.16
0.65
0.33

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
164
211
233
260
261
238
240
261
313
320
Fixed Assets
52
56
60
72
70
71
69
67
77
77
Current Assets
105
143
165
185
183
157
164
185
228
234
Capital Work in Progress
1
4
2
0
4
3
0
2
0
1
Investments
0
0
0
0
0
0
0
0
0
7
Other Assets
111
151
172
189
187
164
172
192
237
236
Total Liabilities
164
211
233
260
261
238
240
261
313
320
Current Liabilities
92
111
143
154
163
160
153
166
209
203
Non Current Liabilities
16
45
30
46
38
34
34
36
40
47
Total Equity
55
55
60
60
60
45
53
59
64
69
Reserve & Surplus
40
40
48
51
53
38
38
43
48
53
Share Capital
13
13
14
14
14
14
15
15
16
16

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
-1
-8
1
-0
-2
0
0
0
3
Investing Activities
-5
-14
-8
-4
-8
-5
-6
-10
-22
-19
Operating Activities
15
-19
6
1
8
23
22
27
-2
23
Financing Activities
-7
32
-6
4
0
-20
-17
-17
24
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Apr 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
44.98 %
44.84 %
46.87 %
49.57 %
49.57 %
52.00 %
52.00 %
52.00 %
51.61 %
51.61 %
51.61 %
51.61 %
51.23 %
51.23 %
51.23 %
50.86 %
50.86 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.13 %
0.13 %
0.13 %
0.14 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
37.31 %
38.37 %
35.73 %
32.97 %
32.88 %
31.30 %
31.45 %
31.49 %
32.13 %
32.07 %
32.00 %
32.19 %
32.63 %
32.15 %
32.36 %
33.15 %
32.57 %
Others
17.72 %
16.79 %
17.40 %
17.46 %
17.55 %
16.70 %
16.55 %
16.52 %
16.26 %
16.32 %
16.40 %
16.20 %
16.13 %
16.49 %
16.28 %
15.86 %
16.43 %
No of Share Holders
12,648
16,531
16,319
16,049
16,223
16,223
16,317
16,170
16,466
16,029
15,869
15,529
15,060
14,772
15,014
16,007
15,667

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1 1 1 0.00 1 1 1 1.2 0.00
Dividend Yield (%) 0.00 1.3 1.43 3.13 0.00 0.93 1.55 1.1 1.43 0.00

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20182 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20182 days ago
Announcement under Regulation 30 (LODR)-Scheme of Arrangement9 days ago
Closure of Trading WindowMar 25, 2025
Withdrawal Of Promoter Reclassification Request.Mar 20, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Integrated Filing (Financial)Feb 14, 2025
Standalone And Consolidated Financial Results For The Quarter Ended 31.12.2024.Feb 13, 2025
Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended 30.09.2024.Feb 13, 2025
Board Meeting Outcome for Outcome Of The Board MeetingFeb 13, 2025
Board Meeting Intimation for Board Meeting IntimationJan 24, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Change In The Name Of RTAJan 02, 2025
Announcement under Regulation 30 (LODR)-Meeting UpdatesDec 03, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 28, 2024
Disclosure Regarding Reclassification Of Promoter GroupNov 22, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Board Meeting Outcome for Un-Audited Financial Results For The Quarter & Half Year Ended 30.09.2024.Nov 14, 2024
Un-Audited Financial Results For The Quarter Ended 30.09.2024.Nov 14, 2024
Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended 30.09.2024Nov 05, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 18, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 15, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 01, 2024
Closure of Trading WindowSep 27, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 26, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2024
Addendum To The Outcome Of The Board MeetingSep 11, 2024
Board Meeting Outcome for Outcome Of The Board MeetingSep 09, 2024
Notice For The 37Th Annual General Meeting.Sep 02, 2024
Board Meeting Intimation for 1. Allotment Of Equity Shares To The Employees Of The Company Upon Conversion Of Stock Options Vested On Them.2. To Consider Expanding Its Manufacturing Presence To Meet Growing Demand For API''s.Aug 30, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2024
Reg. 34 (1) Annual Report.Aug 30, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2024
Dividend And 37Th Annual General Meeting Of The Company.Aug 12, 2024
Unaudited Financial Results For The Quarter Ended 30.06.2024.Aug 12, 2024
Board Meeting Outcome for Outcome Of The Board MeetingAug 12, 2024
Board Meeting Intimation for Inter Alia Take On Record And Approve The Un-Audited Financial Results For The Quarter Ended 30.06.2024.Jul 26, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJul 16, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 04, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateJun 28, 2024
Closure of Trading WindowJun 25, 2024
Disclosure under Regulation 30A of LODRJun 03, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2024
Corporate Action-Board approves DividendMay 29, 2024
Audited Financial Results_31.03.2024May 28, 2024
Board Meeting Outcome for Outcome Of The Board MeetingMay 28, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2024

Technical Indicators

RSI(14)
Neutral
75.98
ATR(14)
Volatile
7.58
STOCH(9,6)
Neutral
62.48
STOCH RSI(14)
Overbought
96.13
MACD(12,26)
Bullish
3.95
ADX(14)
Strong Trend
34.23
UO(9)
Bearish
61.36
ROC(12)
Uptrend And Accelerating
47.00
WillR(14)
Overbought
-13.16